References
- Handog E, Gabriel T, Pineda R. Management of cutaneous tuberculosis. Dermatol. Ther.21, 154–161 (2008).
- WHO. Global Tuberculosis Control: Surveillance, Planning, Financing: WHO report 2011. WHO, Geneva, Switzerland (2011).
- Al-Hajoj S. Review: tuberculosis in Saudi Arabia: can we change the way we deal with the disease? J. Infect. Public Health 3, 17–24 (2010).
- Hay R. Editorial review: cutaneous infection with Mycobacterium tuberculosis: how has this altered with the changing epidemiology of tuberculosis? Curr. Opin. Infect Dis. 18, 93–95 (2005).
- Iqbal AB. Clinical patterns of cutaneous tuberculosis at King Fahad Hospital of the University in Al-Khobar, Saudi Arabia over 13 years. Saudi Med. J. 30(4), 447–449 (2009)
- WHO EMRO.Stop Tuberculosis Programme. WHO, Geneva, Switzerland(2012).
- Tappeiner G, Klaus W. Tuberculosis and other mycobacterial infections.In: Fitzpatrick’s Dermatology in General Medicine. Freedberg I (Ed.). McGraw Hill, NY, USA, 1933–1945 (2003).
- WHO. Fixed-dose combination tablets for the treatment of tuberculosis: report of an informal meeting held in Geneva. Tuesday, 27 April 1999. World Health Organization/TB/99.267.